STAOF yields 5714.29% · PFE yields 6.13%● Live data
📍 STAOF pulled ahead of the other in Year 1
Combined, STAOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of STAOF + PFE for your $10,000?
Sing Tao News Corporation Limited publishes and distributes newspapers, magazines, and books to readers in the People's Republic of China, North America, Australia, and Europe. The company publishes Chinese and English newspapers; and magazines that primarily focuses on current affairs and entertainment, lifestyle, and trends. It also publishes books in various categories, including parenting, travel, health, self-improvement, lifestyle, and culture. In addition, the company offers a multi-media platform for recruitment advertising under the JobMarket, HeadlineJobs.hk, and The StandardJobs titles. Further, it sells and distributes repackaged information and digital content created by its various media businesses, as well as third party content providers; and engages in the radio broadcasting, printing, securities trading and investment, and software development activities. Additionally, the company engages in the property holding activities; distribution of print-media publications; and operation of a Website. Sing Tao News Corporation Limited was founded in 1938 and is headquartered in Tseung Kwan O, Hong Kong.
Full STAOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.